Angelini Pharma S.p.A. has completed its acquisition of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), with each share of Catalyst common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE